NCT02666196View on ClinicalTrials.gov

A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered DAA-I in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Healthy

Interventions

DRUG

DAA-I

DRUG

Placebo

All Listed Sponsors

lead

National University Hospital, Singapore

OTHER

NCT02666196 - A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered DAA-I in Healthy Subjects | Biotech Hunter | Biotech Hunter